Both in Pharmaceuticals
Standard BioTools vs Abeona Therapeutics
Over the past year LAB returned −50.7% and ABEO returned −11.1%; their daily moves had a correlation of 0.25.
LAB −50.7% ABEO −11.1%Growth of $1, one year, split-adjusted
| Metric | LAB | ABEO |
|---|---|---|
| Price | $0.6108 | $4.25 |
| Market cap | $241.1M | $243.0M |
| Today | +0.15% | 0.00% |
| 1 month | −19.9% | −16.8% |
| 6 months | −37.6% | −27.1% |
| Year to date | −52.3% | −19.4% |
| 1 year | −49.1% | −11.6% |
| Revenue growth (YoY) | −7.6% | +2745.0% |
| Gross margin | 52.4% | 63.3% |
| Net margin | −133.1% | −177.4% |
| P/E (TTM) | 2.8× | — |
| Price / sales | 2.8× | 9.5× |
| Net cash | $476.4M | $131.8M |
| Dividend yield | — | — |
| Volatility (60d) | 45.5% | 52.9% |
| Short % of float | 1.1% | 36.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).